Skip to main content

Table 4 Multivariable regression analysis for predictors of recurrent visits at the Cardiac Emergency Department

From: Importance of confirming the underlying diagnosis in patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): a single-centre retrospective cohort study

 

Adjusted ORa

95% CI

p value

hsTnT, per 100 ng/L increase

0.99

0.94–1.04

0.63

CK, per 100U/L increase

1.01

0.93–1.09

0.86

ST-deviation at presentation

0.61

0.32–1.14

0.12

Absence of coronary atherosclerosis on ICA

0.78

0.39–1.55

0.48

Echocardiography performed

0.76

0.36–1.58

0.46

LVEF ≤ 45%

1.50

0.56–4.02

0.42

Wall motion abnormalities

0.74

0.32–1.76

0.50

Additional imaging (composite of CMR, CT-angiography, left ventriculography)

0.42

0.21–0.85

0.016

CMR performed

0.43

0.17–1.09

0.076

CT-angiography performed

0.60

0.22–1.63

0.31

Left ventriculography performed

0.38

0.12–1.20

0.097

MINOCA with diagnosis

0.53

0.25–1.10

0.088

Medication at discharge

   

DAPT

1.52

0.78–2.93

0.22

Oral anticoagulation

1.57

0.47–5.27

0.47

Beta-blocker

0.85

0.44–1.63

0.62

ACE-inhibitor or ARB

0.51

0.27–0.97

0.039

Statin

0.97

0.48–1.96

0.93

  1. hsTnT: high-sensitivity troponin T; CK: creatine kinase; LVEF: left ventricular ejection fraction; CMR: cardiac magnetic resonance imaging; CT-angiography: computed tomography angiography; MINOCA: myocardial infarction with non-obstructive coronary arteries; DAPT: dual antiplatelet therapy; ACE: angiotensin-converting enzyme; ARB: angiotensin II receptor blocker
  2. aCovariates used for correction: age, gender, BMI, current smoker, previous myocardial infarction, atrial fibrillation